Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghiorzo

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Frontiers in Medicine|December 6, 2024
Bridging the educational gaps of health professionals in oncogenomics: results from a pilot e-learning courseEmilia Stellacci, Simone Martinelli, Pietro Carbone, et al.
Pigment Cell & Melanoma Research|November 20, 2015
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanomaVirginia Andreotti, Alessandra Bisio, Brigitte Bressac-de Paillerets, et al.
International Journal of Molecular Sciences|March 11, 2023
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World SettingIrene Vanni, Lorenza Pastorino, Enrica Teresa Tanda, et al.
American Journal of Medical Genetics|January 25, 2002
High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma familiesMichela Mantelli, Monica Barile, Paola Ciotti, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 9, 2026
Age-specific melanoma risk associated with nevi: a pooled analysis from the M-SKIP projectGiulia Doi, Aurora Gaeta, Simone Ribero, et al.
The Journal of Investigative Dermatology|November 19, 2010
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindredsJulie M Lang, Michael Shennan, Jenny C-N Njauw, et al.
Journal of the National Cancer Institute|June 20, 2002
Geographical variation in the penetrance of CDKN2A mutations for melanomaD Timothy Bishop, Florence Demenais, Alisa M Goldstein, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2018
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortiumAlexander J Stratigos, Maria Concetta Fargnoli, Arcangela De Nicolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup StudyMilena Casula, Maria Colombino, Maria P Satta, et al.
Journal of Medical Genetics|February 28, 2012
CDKN2A is the main susceptibility gene in Italian pancreatic cancer familiesPaola Ghiorzo, Giuseppe Fornarini, Stefania Sciallero, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Frontiers in Medicine|December 6, 2024
Bridging the educational gaps of health professionals in oncogenomics: results from a pilot e-learning courseEmilia Stellacci, Simone Martinelli, Pietro Carbone, et al.
Pigment Cell & Melanoma Research|November 20, 2015
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanomaVirginia Andreotti, Alessandra Bisio, Brigitte Bressac-de Paillerets, et al.
International Journal of Molecular Sciences|March 11, 2023
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World SettingIrene Vanni, Lorenza Pastorino, Enrica Teresa Tanda, et al.
American Journal of Medical Genetics|January 25, 2002
High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma familiesMichela Mantelli, Monica Barile, Paola Ciotti, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 9, 2026
Age-specific melanoma risk associated with nevi: a pooled analysis from the M-SKIP projectGiulia Doi, Aurora Gaeta, Simone Ribero, et al.
The Journal of Investigative Dermatology|November 19, 2010
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindredsJulie M Lang, Michael Shennan, Jenny C-N Njauw, et al.
Journal of the National Cancer Institute|June 20, 2002
Geographical variation in the penetrance of CDKN2A mutations for melanomaD Timothy Bishop, Florence Demenais, Alisa M Goldstein, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2018
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortiumAlexander J Stratigos, Maria Concetta Fargnoli, Arcangela De Nicolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup StudyMilena Casula, Maria Colombino, Maria P Satta, et al.
Journal of Medical Genetics|February 28, 2012
CDKN2A is the main susceptibility gene in Italian pancreatic cancer familiesPaola Ghiorzo, Giuseppe Fornarini, Stefania Sciallero, et al.
Pageof 15